Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.

S1PR1 helps control inflammation in blood vessel cells by affecting gene activity differently in various cell types and locations.

LRIG1 is linked to better survival in Merkel cell carcinoma.

The FDA approved a new Pfizer drug for hair loss in teens.

ATP-sensitive potassium channels are important for hair growth.

A child with ectodermal dysplasia-syndactyly syndrome has a new mutation in the NECTIN4 gene.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Phosphorus affects walnut root hair growth by altering auxin levels.

Skin irritants can promote hair growth by affecting specific skin proteins.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Pantothenic acid helps mink hair follicles grow by affecting certain cell signals.

Blocking SEPT4 might help heal wounds and regrow hair faster.

Krt16-deficient mice help understand skin disorders like PC and FNEPPK.

Erlotinib may cause scarring hair loss.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Ephrins slow down skin and hair follicle cell growth.

Edar signaling is crucial for controlling hair growth and regression.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

The Fas/FasL pathway may play a role in alopecia areata.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Genetic mutations linked to ectodermal dysplasias and hair loss were identified in Pakistani families.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Plet-1 protein helps hair follicle cells move and stick to tissues.

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

Dermal EZH2 controls skin cell growth and differentiation in mice.